| abstract |
A transdermal drug delivery system for the treatment of an eyelid disease comprising a pressure sensitive adhesive layer provided on a backing, where the pressure sensitive adhesive layer comprises a steroid, where the system is applied topically. to a skin surface of an eyelid of a patient in need of treatment, and where the steroid is selected from the group consisting of clobetasol propionate, clobetasol butyrate, betamethasone dipropionate, amcinonide, and loteprednol etabonate. |